Applied Biological Chemistry

The Korean Society for Applied Biological Chemistry (한국응용생명화학회)
권호 표지

A Study on Preparation and Binding Properties of Germanium-fortified Yeast

게르마늄강화효모의 제조 및 이의 게르마늄 결합에 관한 연구

  • 이성희 (게란티제약(주) 중앙연구소) ;
  • 안상두 (중앙대학교 화학과) ;
  • 노숙령 (중앙대학교 식품영양학과) ;
  • 손창욱 (게란티제약(주) 중앙연구소)
  • Published : 2005.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to identify binding properties of germanium (Ge) in Germanium-fortified Yeast using optimum manufacturing process. The ratio of yeast cell and germanium solution was 1 : 0.5 (50%), and pH 6.5, $35^{\circ}C$ and 20 h during fermentation, and Germanium-fortified Yeast produced. In results of the XRD, NMR and FT-IR analysis, it was different adding inorganic Ge $(GeO_2)$ during fermentation process from transformed into germanium in Germanium-fortified Yeast. And germanium concentration was not shown any difference before and after in the dialysis test with SGF (simulated gastric fluids). Therefore, Germanium-fortified Yeast of Geranti made by using biosynthetic technology was considered that transformed into organic properties during fermentation process. And, this result showed that Germanium-fortified Yeast was not dissociated under SGF (simulated gastric fluids) condition because of its structural binding safety. Thus, Germanium-fortified Yeast was transformed into organic germanium during biosynthetic cultivation. It is expected that this Germanium-fortified Yeast can be applied as a new dietary functional materials for cellular immunity, recovery of injured cells and immune system, and possible anticancer activities by activation immune cells like macrophage.

본 연구는 게르마늄 강화 효모의 제조 공정을 위한 최적의 조건을 잡고 제조된 게르마늄 강화 효모 내의 게르마늄의 결합 상태 확인을 목적으로 하였으며, 그 결과는 다음과 같다. 균체와 게르마늄 용액 혼합 비율 1 : 0.5(50%)로 하여 균체와 게르마늄 배양시 최적 조건인 pH 6.5, 온도 $35^{\circ}C$ 그리고 배양 시간은 20시간 배양하는 것이 높은 함량의 게르마늄을 효모 균체 내로 유입시켜 게르마늄 강화 효모를 생산하였으며, 이의 배양 과정을 통해 생산된 게르마늄 강화 효모는 배양 과정 동안의 구조적 변화에 의해 효모 내에 유입된 무기 형태인 $GeO_2$ 게르마늄과는 다른 구조를 형성하고 있었다. 또한 NMR 및 FTIR 실험을 실시한 결과 게르마늄 강화 효모의 발효 과정에 첨가한 무기 형태의 $GeO_2$가 배양 과정 동안 균체 내에서 게르마늄이 유입되는 과정에서 게르마늄이 단백질(혹은 펩타이드)과 결합하여 구조에 변화를 형성하였으며, 인공위액 안에서 투석막을 이용한 투석 전후에 따른 게르마늄 총량에서 투석 전후에 따른 차이가 나타나지 않았다. 따라서 게르마늄 강화 효모는 생합성 기법을 이용하여 게르마늄을 강화한 유기 게르마늄 생산방법으로 배양 과정을 통해 구조적으로 안전한 유기 게르마늄을 형성하여 인공위액 조건에서도 해리되지 않는 것으로 보여지며, 각종 암, 성인병의 예방과 치료, 인체 면역력의 증진 등 건강 증진을 위한 새로운 기능성 원료로의 활용이 기대되며, 이에 대한 지속적인 연구가 사료된다.

Keywords

References

  1. Sandra, G. (1988) Therapeutic effects of organic germanium. Med. Hypotheses 26, 207-215 https://doi.org/10.1016/0306-9877(88)90101-6
  2. Arimori, S., Watanabe, K., Yoshida, M. and Nagao, T. (1981) Effect of Ge-132 as Immunomodulator, In: Immunomodulation by Microbial Products and Related Synthetic Compounds. Int. Symp. Osaka July 27-29
  3. Lee, H. K., Kim, J. S. and Kang, T. B. (2004) Extraction of Organic Germanium Compound from Garlic. Inst. Natural Sci. Sangmyung Univ. 12, 1-18
  4. Schroeder, H. A. and Balassa, J. J. (1967) Arsenic, germanium, tin, and vanadium in mice: Effects on growth, survival and tissue levels. J. Nutr. 92, 245-252
  5. Asai, K. (1980) In Miracle Cure-Organic germanium. Japan publications Inc. (USA)
  6. Ishida, N., Suzuki, F. and Hayashi, Y. (1979) Antitumor effects of organic germanium compound (Ge-132) in mouse tumors. Proc. the Japanese Cancer Assoc. Annual meeting, p. 193
  7. Li, A. P., Dahl, A. R. and mn, J. O. (1982) In vitro cytotoxicity and genotoxicity of dichloride and dibutylgermanium dichloride. Toxicol. Appl. Pharmacol. 64, 482-485 https://doi.org/10.1016/0041-008X(82)90245-9
  8. Kada, T., Mochizuki, H. and Miyao, K. (1984) Antimutagenic effects of germanium oxide on Trp-2-indued frame shift mutations in Salmonella typhimurium TA98 and TA1538. Mutat. Res. 125, 145-151 https://doi.org/10.1016/0027-5107(84)90066-6
  9. Klapcinska, B. and Clmielowski, J. (1986) Binding of germanium to Pseudomonas putida cells. Appl. Environ. Microbiol. 51, 1144-1147
  10. Wei, X. S. (1992) Effect of yeast on bioenrichment of germanium. Food Science. 149, 49-54
  11. Lynn, M. R. and Geoffrey, M. G. (1997) Mutants of Sacchromyces cerevisiae defective in vacuolar function a role for the vacuole in toxic metal ion detoxification. Microbiol. Lett. 152, 293-298 https://doi.org/10.1111/j.1574-6968.1997.tb10442.x
  12. VanDyke, M. I., Lee, H. and J. T. Travors. (1989) Germanium toxicity in selected bacterial and yeast stains. J. Ind. Microbiol. 4, 299-30 https://doi.org/10.1007/BF01577353
  13. Anna, K. K. (1990) In Yeasts and yeast-like organisms. (1st ed.), VCH Press, New York, pp. 131-205
  14. Park, J. H., Kang, M. S., Kim, H. I., Chung, B. H., Lee, K. H. and Moon, W. K. (2003) Study on immuno-stimulating activity of glucan isolated from the cell wall of yeast mutant Saccharomyces cerevisiae IS2. Korean J. Food Sci. Technol. 35, 483-492
  15. Kang, J. K., Kim, Y. B., Kim, K. H. and Ha, S. K. (1986) A study of the immunogenicity and reactogenicity of the Smith Kline_RIT recombinant DNA yeast-derived hepatitis B in healthy young adults. Korean J. Int. Med. 31, 318-322
  16. Yu, K. W., Oh, S. H., Choi, Y. S., Hwang, W. J. and Suh, H. J. (2001) The reduction effect of yeast hydrolysate SCP-20 on premenstrual syndrome. J. Korean Soc. Food Sci. Nutri. 30, 1000-1003
  17. Song, W. J., Lee, S. C. and Oh, T. K (1995) Preparation of organic germanium by yeast cell. Kor. J. Appl. Microbiol. Biotechnol. 23, 87-90
  18. Sanai, T., Oochi, N. and S. Okuda. (1990) Subacute nephrotoxicity of germanium dioxide in the experimental animal. Toxicol. Appl. Pharmacol. 103, 345-353 https://doi.org/10.1016/0041-008X(90)90234-L
  19. Sanai, T., S. Okuda, and K. Onoyarna. (1991) Chronic tubulointestitial changes induced by germanium dioxide in comparison with carboxyrthylgermanium sesquioxide. Kidney. Int. 40, 882-890 https://doi.org/10.1038/ki.1991.289